BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32930385)

  • 1. CD56
    Kobyzeva PA; Streltsova MA; Erokhina SA; Kanevskiy LM; Telford WG; Sapozhnikov AM; Kovalenko EI
    J Leukoc Biol; 2020 Oct; 108(4):1379-1395. PubMed ID: 32930385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
    Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
    Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
    J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C.
    Kim KH; Yu HT; Hwang I; Park S; Park SH; Kim S; Shin EC
    Front Immunol; 2019; 10():2865. PubMed ID: 31867015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
    Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
    Front Immunol; 2019; 10():687. PubMed ID: 31001281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
    Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
    Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A.
    Streltsova MA; Erokhina SA; Kanevskiy LM; Lee DA; Telford WG; Sapozhnikov AM; Kovalenko EI
    PLoS One; 2018; 13(12):e0208469. PubMed ID: 30517188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK Cell Activity and CD57
    Flórez-Álvarez L; Blanquiceth Y; Ramírez K; Ossa-Giraldo AC; Velilla PA; Hernandez JC; Zapata W
    Front Immunol; 2020; 11():537044. PubMed ID: 33042136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.
    Merino A; Zhang B; Dougherty P; Luo X; Wang J; Blazar BR; Miller JS; Cichocki F
    J Clin Invest; 2019 Jun; 129(9):3770-3785. PubMed ID: 31211698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral Blood.
    Kovalenko EI; Zvyagin IV; Streltsova MA; Mikelov AI; Erokhina SA; Telford WG; Sapozhnikov AM; Lebedev YB
    Front Immunol; 2020; 11():613882. PubMed ID: 33664730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.
    Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL
    J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
    Newhook N; Fudge N; Grant M
    Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine activation induces human memory-like NK cells.
    Romee R; Schneider SE; Leong JW; Chase JM; Keppel CR; Sullivan RP; Cooper MA; Fehniger TA
    Blood; 2012 Dec; 120(24):4751-60. PubMed ID: 22983442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.
    Kristensen AB; Wragg KM; Vanderven HA; Lee WS; Silvers J; Kent HE; Grant MD; Kelleher AD; Juno JA; Kent SJ; Parsons MS
    Clin Exp Immunol; 2022 Dec; 210(2):163-174. PubMed ID: 36053502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
    Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
    Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.